ArticleGastroenterology2021
The Impact of the COVID-19 Pandemic on Barrett's Esophagus and Esophagogastric Cancer.
Article in Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Time to Therapy May Not Impact Diagnosis Upstaging in Patients Referred for Management of Luminal Gastrointestinal Neoplasia.Digestive diseases and sciences · 2025Article
- Impact of the COVID-19 pandemic on esophageal cancer resource allocation: a systematic review.Journal of thoracic disease · 2024Review
- Impact of the COVID-19 pandemic on bladder cancer patients: a multicenter real-world study.The Journal of international medical research · 2023Article
- Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study.The British journal of surgery · 2023Article
- Development and validation of a multivariable risk factor questionnaire to detect oesophageal cancer in 2-week wait patients.Clinics and research in hepatology and gastroenterology · 2023Article
- Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy.Tumori · 2023Article
- Network pharmacology and bioinformatics analysis identifies potential therapeutic targets ofFrontiers in endocrinology · 2023Article
- The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020.International journal of cancer · 2022Article
- Cancer diagnosis in Catalonia (Spain) after two years of COVID-19 pandemic: an incomplete recovery.ESMO open · 2022Article
- Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European survey.European journal of public health · 2022Article
- Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.Frontiers in endocrinology · 2022Article
- The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers.European journal of cancer (Oxford, England : 1990) · 2021Article
- Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.ESMO open · 2021Article
- The impact of the COVID-19 pandemic on the oncology services demand in a middle-income setting with universal health insurance.Colombia medica (Cali, Colombia)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.